“2020 consensus guideline for optimal approach to the diagnosis and treatment of HER2-positive breast cancer in Bosnia and Herzegovina” (2021) Biomolecules and Biomedicine, 21(2), pp. 120–135. doi:10.17305/bjbms.2020.4846.